A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines
Authors:
- Benjamin AscherBABenjamin Ascher
- Benjamin ZakineBZBenjamin Zakine
- Philippe KestemontPKPhilippe Kestemont
- Martine BaspeyrasMBMartine Baspeyras
- Ali BougaraABAli Bougara
- José SantiniJSJosé Santini
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (2) , 223-233
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cosmetic Uses of Botulinum Neurotoxin Type AArchives of Facial Plastic Surgery, 2002
- A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJournal of the American Academy of Dermatology, 2002
- Quantification of the efficacy of botulinum toxin type A by digital image analysisJournal of the American Academy of Dermatology, 2001
- Pharmacology of botulinum toxinJournal of the American Academy of Dermatology, 2000
- The cosmetic uses of Botulinum toxin type AInternational Journal of Dermatology, 1999
- Multiple Testings: Multiple Comparisons and Multiple EndpointsDrug Information Journal, 1998
- Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection techniqueJournal of the American Academy of Dermatology, 1996
- Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled StudyPlastic and Reconstructive Surgery, 1994
- Aesthetic Indications for Botulinum Toxin InjectionPlastic and Reconstructive Surgery, 1994
- Treatment of Glabellar Frown Lines with C. Botulinum‐A ExotoxinThe Journal of Dermatologic Surgery and Oncology, 1992